FDA — authorised 18 January 2011
- Marketing authorisation holder: PARAPRO LLC
- Status: approved
FDA authorised Natroba on 18 January 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 18 January 2011.
PARAPRO LLC holds the US marketing authorisation.